Drug-eluting stents

Coronary disease

Treatment of Femoropopliteal Lesions with Drug-Coated Balloons: IVUS vs. Conventional Angiography

Angiography has traditionally been the standard imaging technique to guide endovascular therapy (EVT) in patients with peripheral...

Dr. Andrés Rodríguez - 30 September, 2025

Coronary disease

OCT Assessment of Bioresorbable Scaffold Performance across Different Types of Plaque

The development of bioresorbable magnesium scaffolds (RMS) has generated significant expectation in the field of percutaneous coronary...

Dr. Omar Tupayachi - 3 July, 2025

Chronic Coronary Syndromes

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

In a constant strive to achieve life time management, interventional cardiologists focus on optimizing coronary scaffolds, which...

Dr. Omar Tupayachi - 20 June, 2025

Chronic Coronary Syndromes

Chronic Stent Recoil and Its Long-Term Effects

The evolution of stent technology—including new scaffold designs, thinner struts, and more biocompatible polymers—has brought about an...

Dr. Omar Tupayachi - 17 June, 2025

Bifurcations

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary...

Dr. Andrés Rodríguez - 31 March, 2025

Chronic Coronary Syndromes

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and...

Dr. Omar Tupayachi - 25 March, 2025

Chronic Ischemic cardiopathy

Early and Late Outcomes with the ABSORB Bioresorbable Scaffold

Coronary angioplasty with drug-eluting stents (DES) is associated with a 2-3% annual incidence of stent-related events, a...

Dr. Andrés Rodríguez - 5 March, 2025

Acute coronary syndromes

DCB-BIF Trial: Randomized Study of Side Branch Drug-Coated Balloon Angioplasty Following Provisional Stenting

Coronary bifurcations present technical challenges that should be addressed for adequate coronary geometry. The first treatment option...

Dr. Omar Tupayachi - 21 January, 2025

Treatment of Femoropopliteal Lesions with Drug-Coated Balloons: IVUS vs. Conventional Angiography

OCT Assessment of Bioresorbable Scaffold Performance across Different Types of Plaque

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

Chronic Stent Recoil and Its Long-Term Effects

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

Early and Late Outcomes with the ABSORB Bioresorbable Scaffold

DCB-BIF Trial: Randomized Study of Side Branch Drug-Coated Balloon Angioplasty Following Provisional Stenting

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Accesos